{
  "id": "0cec9d01b5c5ce76",
  "title": "STAT+: FDA reverses course, agrees to review Moderna\u2019s flu vaccine",
  "description": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.",
  "content": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/02/18/fda-moderna-reverse-course-flu-vaccine/?utm_campaign=rss",
  "published_at": "2026-02-18T12:29:42+00:00",
  "fetched_at": "2026-02-19T00:30:34.211663+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: FDA reverses course, agrees to review Moderna\u2019s flu vaccine",
    "description": "The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.",
    "url": "https://www.statnews.com/2026/02/18/fda-moderna-reverse-course-flu-vaccine/?utm_campaign=rss",
    "published": "2026-02-18T12:29:42+00:00",
    "source": "STAT"
  }
}